The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen
Abstract
Unmethylated CpG dinucleotides in bacterial DNA or synthetic oligodeoxynucleotides (ODN) cause B cell proliferation and Ig secretion, monocyte cytokine secretion, and activation of NK cell lytic activity and IFN-γ secretion in vivo and in vitro. The potent immune activation by CpG ODN suggests possible utility for enhancing immune responses to vaccines. Mice immunized with recombinant hepatitis B virus surface Ag and a CpG ODN as an immune enhancer have titers of Abs against HBsAg (anti-HBs) that are five times higher than those of mice immunized with HBsAg and the standard adjuvant, aluminum hydroxide (alum). Ab titers in mice immunized with HBsAg and both CpG ODN plus alum were 35 times higher than the titers in mice immunized with alum alone, indicating a strong synergistic interaction between the CpG ODN and alum. ODN without CpG motifs had little or no immune-enhancing activity at the doses used herein. Alum induces a Th2 humoral response (mostly IgG1) and no CTL. In contrast, CpG ODN gives a strong Th1 response with predominantly IgG2a Abs and CTL, even when mixed with alum. In vitro studies to determine possible mechanisms of CpG immune-enhancing effects show that CpG ODN induce expression of costimulatory molecules on Ag-presenting cells and drive B cell isotype switching in the appropriate cytokine milieu. These studies demonstrate that CpG ODN are promising new immune enhancers for vaccination applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CpG motifs in bacterial DNA trigger direct B-cell activation
Krieg, A. M., Yi, A.-K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., & Klinman, D. M. (1995) · Nature · doi:10.1038/374546a0 · Cited by 3,508
Self-citationKlinman, D. M., Yi, A. K., Beaucage, S. L., Conover, J., & Krieg, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2879 · Cited by 1,477
Self-citationRehermann, B., Ferrari, C., Pasquinelli, C., & Chisari, F. V. (1996) · Nature Medicine · doi:10.1038/nm1096-1104 · Cited by 854
Long-Term Follow-up of HBeAg-Positive Patients Treated with Interferon Alfa for Chronic Hepatitis B
Niederau, C., Heintges, T., Lange, S., Goldmann, G., Niederau, C. M., Mohr, L., & Häussinger, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342202 · Cited by 803
B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.
Coffman, R. L., Ohara, J., Bond, M. W., Carty, J., Zlotnik, A., & Paul, W. E. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.12.4538 · Cited by 796
Ballas, Z. K., Rasmussen, W. L., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1840 · Cited by 754
Self-citationCpG islands as gene markers in the vertebrate nucleus
Bird, A. P. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90294-0 · Cited by 678
Cowdery, J. S., Chace, J. H., Yi, A. K., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.12.4570 · Cited by 423
Self-citationHalpern, M. D., Kurlander, R. J., & Pisetsky, D. S. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0009 · Cited by 391
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA
Messina, J. P., Gilkeson, G. S., & Pisetsky, D. S. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.6.1759 · Cited by 371
Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T., & Tokunaga, T. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02102.x · Cited by 366
Stavnezer, J. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60866-4 · Cited by 324
Asthma--An Epidemic in the Absence of Infection?
Cookson, W. O. C. M., & Moffatt, M. F. (1997) · Science · doi:10.1126/science.275.5296.41 · Cited by 308
Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 291
Self-citationActivation of human B cells by phosphorothioate oligodeoxynucleotides.
Liang, H., Nishioka, Y., Reich, C. F., Pisetsky, D. S., & Lipsky, P. E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118894 · Cited by 287
Yi, A. K., Klinman, D. M., Martin, T. L., Matson, S., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5394 · Cited by 281
Self-citationAntisense oligonucleotides: towards clinical trials
Agrawal, S. (1996) · Trends in Biotechnology · doi:10.1016/0167-7799(96)10053-6 · Cited by 265
Michel, M. L., Davis, H. L., Schleef, M., Mancini, M., Tiollais, P., & Whalen, R. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5307 · Cited by 262
Self-citationZHAO, Q., MATSON, S., HERRERA, C. J., FISHER, E., YU, H., & KRIEG, A. M. (1993) · Antisense Research and Development · doi:10.1089/ard.1993.3.53 · Cited by 232
Self-citationYi, A. K., Chace, J. H., Cowdery, J. S., & Krieg, A. M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.2.558 · Cited by 206
Self-citationMitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells.
Rothman, P., Lutzker, S., Cook, W., Coffman, R., & Alt, F. W. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.6.2385 · Cited by 206
Berton, M. T., Uhr, J. W., & Vitetta, E. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.8.2829 · Cited by 174
Snapper, C. M., & Paul, W. E. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.1.10 · Cited by 163
Davis, H. (1996) · Vaccine · doi:10.1016/0264-410x(95)00255-y · Cited by 158
Self-citationImmune stimulation--a class effect of phosphorothioate oligodeoxynucleotides in rodents.
Monteith, D. K. B., Henry, S. P., Rb, H., et al. (1997) · PubMed · Cited by 124
An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA
Krieg, A. Μ. (1996) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(96)90004-9 · Cited by 120
Self-citationGermline transcripts of the murine immunoglobulin γ2a gene: structure and induction by IFN-γ
Collins, J. T., & Dunnick, W. A. (1993) · International Immunology · doi:10.1093/intimm/5.8.885 · Cited by 92
Hepatitis B Vaccines in Clinical Practice
Ellis, R. W. (2024) · CRC Press eBooks · doi:10.1201/9781003573852 · Cited by 87
Progress in antisense therapeutics
Crooke, S. T. (1996) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199607)16:4<319::aid-med2>3.0.co;2-# · Cited by 79
Cited by
CpG Motifs in Bacterial DNA and Their Immune Effects
Krieg, A. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064842 · Cited by 2,573
Self-citationTherapeutic potential of Toll-like receptor 9 activation
Krieg, A. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2059 · Cited by 1,246
Self-citationDNA Vaccines: Immunology, Application, and Optimization
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.927 · Cited by 1,207
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., & Klinman, D. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.10.174 · Cited by 891
Metadata
- Authors
- Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., & Krieg, A. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01
- Volume
- 160
- Issue
- 2
- Pages
- 870-876
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2145464179
- Cited by
- 677
- References
- 29
- FWCI
- 25.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.